Intracerebral injection of SHH-N enhanced tyrosine hydroxylase immunoreactive neuronal expression in the striatum and improved motor performance in PD rats, indicating a specific treatment for PD (Yang et al., 2021). This evidence concerns the gene SHH and Parkinson disease.